Skip to main content

Advertisement

Log in

Pisa Syndrome Associated With Clozapine: A Rare Case Report and Literature Review

  • Case Studies
  • Published:
Spine Deformity Aims and scope Submit manuscript

Abstract

Study Design

Case report.

Introduction

Pisa syndrome (pleurothotonus) is a rare neurologic syndrome, often considered as a consequence of long-term treatment with neuroleptic drugs, defined as more than 10 degrees tonic lateral flexion in upright spine without any significant associated vertebral rotation resembled the leaning tower of Pisa. Unfamiliarity of many neuro- and orthopedic surgeons with this syndrome can lead to unnecessary diagnostic and therapeutic interventions.

Case Report

A 33-year-old woman, who has been treated as a schizophrenic patient for 16 years, was referred to our spine clinic with signs of trunk shift. She was consuming valproic acid 500 mg twice a day and clozapine 100 mg three times daily, as an unchanged regimen for the past 2 years. Few months after treatment with clozapine, her parents noticed that the patient progressively leaned to one side. Physical and imaging examinations revealed a severe left truncal shift associated with right cervical tilt. Drug regimen was changed and clozapine dosage reduced to 200 mg daily, and bipyridine 2 mg daily was added to the therapeutic regimen. By 1 month, the deformity gradually disappeared and normal body posture was restored. At the last follow-up visit, 28 months later, normal body posture was observed to be maintained, and no evidence of spinal deformity was noted.

Conclusions

Spine deformity surgeons visiting patients with abnormal postures of the trunk need to ask the patient about medications they are receiving and should be aware of their neuropsychiatric complications. Even drugs with the minimum risk of dystonia, such as clozapine, may cause dystonic disorders like Pisa syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schwab FJ, Smith VA, Biserni M, et al. Adult scoliosis: a quantitative radiographic and clinical analysis. Spine 2002;27:387–92.

    Article  Google Scholar 

  2. Suzuki T, Matsuzaka H. Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management. CNS Drugs 2002;16:165–74.

    Article  CAS  Google Scholar 

  3. Chen HK, Wu BJ, Shao CH. Drug-induced Pisa syndrome associated with aripiprazole during clozapine treatment. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:707–8.

    Article  Google Scholar 

  4. Pan PY, Chou HW, Cheng CC, et al. Pisa syndrome induced by paliperidone. J Neuropsychiatry Clin Neurosci 2014;26:E3–8.

    Article  Google Scholar 

  5. Yeh YM, Chen YC, Chen CK, et al. Chronic Pisa syndrome associated with switching antipsychotics from olanzapine to ziprasidone. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:162–3.

    Article  CAS  Google Scholar 

  6. Walder A, Greil W, Baumann P. Drug-induced Pisa syndromeunder quetiapine. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:1286–7.

    Article  CAS  Google Scholar 

  7. Ekbom K, Lindholm H, Ljungberg L. New dystonic syndrome associated with butyrophenone therapy. Z Neurol 1972;202:94–103.

    CAS  PubMed  Google Scholar 

  8. Cordeiro Q, Zung S, Vallada H. Pisa syndrome induced by rapid increase and high dosage of risperidone. Arq Neuropsiquiatr 2008;66:896–7.

    Article  Google Scholar 

  9. Shinfuku M, Nakajima S, Uchida H, et al. Pisa syndrome caused by an acetylcholinesterase inhibitor in a patient with dementia with Lewy bodies. Psychiatry Clin Neurosci 2011;65:299.

    Article  Google Scholar 

  10. Cossu G, Melis M, Melis G, et al. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report. Mov Disord 2004;19:1243–4.

    Article  Google Scholar 

  11. Uemura T, Kasai Y, Araki K, et al. Pisa syndrome. J Spinal Disord Tech 2008;21:455–7.

    Article  Google Scholar 

  12. Marchione P, Spallone A, Valente M, et al. Reversible Pisa syndrome associated to subdural haematoma: case-report. BMC Neurol 2014;14:149.

    Article  Google Scholar 

  13. Hazari N, Kate N, Grover S. Clozapine and tardive movement disorders: a review. Asian J Psychiatr 2013;6:439–51.

    Article  Google Scholar 

  14. Kurtz G, Kapfhammer HP, Peuker B. Pisa syndrome in clozapine therapy. Nervenarzt 1993;64:742–6.

    CAS  PubMed  Google Scholar 

  15. Hung TH, Lee Y, Chang YY, et al. Reversible Pisa syndrome induced by clozapine: a case report. Clin Neuropharmacol 2007;30:370–2.

    Article  Google Scholar 

  16. Doherty KM, van de Warrenburg BP, Peralta MC, et al. Postural deformities in Parkinson’s disease. Lancet Neurol 2011;10:538–49.

    Article  Google Scholar 

  17. Schmid CL, Streicher JM, Meltzer HY, et al. Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a barrestin2-independent activation of Akt. Neuropsychopharmacology 2014;39:1902–13.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Farzad Omidi-Kashani MD.

Additional information

Author disclosures: FF (none); FO (none); AB (none).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faridhosseini, F., Omidi-Kashani, F. & Baradaran, A. Pisa Syndrome Associated With Clozapine: A Rare Case Report and Literature Review. Spine Deform 3, 386–389 (2015). https://doi.org/10.1016/j.jspd.2015.02.003

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.jspd.2015.02.003

Keywords

Navigation